A biliary tract biopsy is the removal of small amount of cells and fluids from the duodenum, bile ducts, pancreas, or pancreatic duct. he sample is examined under a microscope.
How the Test is Performed
Your doctor can take a sample for a biliary tract biopsy in different ways.
A needle biopsy can be done if you have a well-defined tumor.
- The biopsy site is cleaned.
- A thin needle is inserted into the area to be tested, and a sample of cells and fluid are removed.
- The needle is then removed.
- Pressure is put on the area to stop any bleeding. The site will be covered with a bandage.
If you have a narrowing or blockage of the bile or pancreatic ducts, a sample can be taken during procedures such as:
- Endoscopic retrograde cholangiopancreatography (ERCP)
- Percutaneous transhepatic cholangiogram (PTCA)
How to Prepare for the Test
You may not be able to eat or drink 8-12 hours or more before the test. Your health care provider will tell you ahead of time what you need to do.
Make sure you have someone to drive you home.
How the Test will Feel
How the test will feel depends on the type of procedure used to remove the biopsy sample. With a needle biopsy, you may feel a sting as the needle is inserted. Some people feel a cramping or pinching feeling during the procedure.
Medicines that stop pain and help you relax are commonly used for other biliary tract biopsy methods.
Why the Test is Performed
A biliary tract biopsy can determine if a tumor started in the liver or spread from another location. It also can determine if the tumor is cancerous.
This test may be done:
A normal result means there are no signs of cancer, disease, or infection in the biopsy sample.
Risks depend on how the biopsy sample was taken.
Risks may include:
- Bleeding at the biopsy site
Cytology analysis - biliary tract; Biliary tract biopsy
Afdahl NH. Diseases of the gall bladder and bile ducts In: Goldman L, Schafer AI, eds.Cecil Medicine
Stockland AH, Baron TH. Endoscopic and radiologic treatment of biliary disease. In: Feldman M, Friedman LS, Brandt LJ, eds.Sleisenger and Fordtran's Gastrointestinal and Liver Disease
Update Date 1/22/2013
Updated by: George F. Longstreth, MD, Department of Gastroenterology, Kaiser Permanente Medical Care Program, San Diego, California. Also reviewed by A.D.A.M. Health Solutions, Ebix, Inc., Editorial Team: David Zieve, MD, MHA, Bethanne Black, Stephanie Slon, and Nissi Wang.